ArticleScientific reports2026
Comet assay and antioxidant enzyme as blood biomarkers of low-dose radiation-induced adaptive response.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the ability of low doses to cause an in vivo radio-adaptive response (RAR) and examined the biological effects of acute low-dose total-body gamma irradiation in rats. Adult male rats were randomly divided into 8 groups. Acute gamma radiation doses of 0.25, 0.5, and 0.75 Gy for groups 2, 3, and 4, respectively, and a 2 Gy challenge dose for group 5 were administered 14 days later. then 0.25, 0.50, and 0.75 Gy, followed by 2 Gy to groups 6, 7, and 8. Twenty-four hours after irradiation, measurements were made of comet assay parameters and antioxidant indicators: Acute gamma exposure resulted in a significant rise in Comet Assay Score CAS (6-16%), Tail Length TL (4.7-7.45 μm), DNA in tail DNA% (11.82-17.76%), Tail Moment TM (1.17-3.78 μm), and Olive Tail Moment OTM (0.53-1.52 µmol/L), as well as dose-dependent increases in GSSG (4.6-9.58 µmol/L), and decrease in SOD (180.4-91.2 U/mL). These results demonstrate the rising detrimental consequences linked to higher acute gamma doses. Lower priming does encourage stronger adaptive responses, according to RAR analysis. The concentrations of GSSG, TL, OTM, and the ratio of Oxidized Glutathione/ Reduced Glutathione GSSG/GSH showed notable linear dose-response associations, indicating their potential as biomarkers for acute gamma radiation biodosimetry. These findings lay the groundwork for future research to verify these markers for dose evaluation and to examine the dynamics of RAR under various challenge doses and postirradiation circumstances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.